Skip to main content

Advertisement

SpringerLink
Log in

Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Patients with refractory interstitial cystitis (IC) underwent testing with sacral nerve modulation via either a traditional percutaneous approach or a staged procedure. Implanted patients were followed with scaled questionnaires and voiding diaries. Twenty-six patients who had a permanent InterStim placed had a reduction in 24-h voids of 51%. More than two-thirds of patients reported a moderate or marked improvement in urinary frequency, urgency, pelvic pain, pelvic pressure, incontinence and overall quality of life. The test to implant rate of a traditional percutaneous procedure was 52%, compared to a staged procedure of 94%. Assessing sensory response at the time of implant reduced the reoperation rate from 43% to 0%. Ninety-six per cent stated they would undergo an implant again and recommend the therapy to a friend. We concluded that sacral nerve modulation can treat refractory IC symptoms. The response to therapy and the reoperation rate are dependent on the technique used to test and implant the device.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

Abbreviations

IC:

Interstitial cystitis

TENS:

Transcutaneous electrical nerve stimulation

References

  1. Baskin LS, Tanagho EA (1992) Pelvic pain without pelvic organs. J Urol 147:683–686

    CAS  Google Scholar 

  2. Fall M, Carlsson CA, Erlandson BE (1980) Electrical stimulation in interstitial cystitis. J Urol 123:192–195

    CAS  Google Scholar 

  3. Geirsson G, Wang Y-H, Lindstrom S, Fall M (1993) Traditional acupuncture and electrical stimulation of the posterior tibial nerve. Scand J Urol Nephrol 27:67–70

    CAS  Google Scholar 

  4. Fall M (1987) Transcutaneous electrical nerve stimulation in interstitial cystitis. Urology 29(Suppl):40–42

    CAS  Google Scholar 

  5. Everaert K, Devulder J, De Muynck M et al. (2001) The pain cycle: implications for the diagnosis and treatment of pelvic pain syndromes. Int Urogynecol J 12:9–14

    CAS  Google Scholar 

  6. Schmidt RA, Bruschini H, Tanagho EA (1979) Urinary bladder and sphincter responses to stimulation of dorsal and ventral sacral roots. Invest Urol 16:300–304

    CAS  Google Scholar 

  7. Schmidt RA, Tanagho EA (1979) Feasibility of controlled micturition through electrical stimulation. Urol Int 34:199–230

    CAS  Google Scholar 

  8. Chai TC, Zhang C, Warren JW, Keay S (2000) Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology 55:643–646

    CAS  Google Scholar 

  9. Maher CF, Carey MP, Dwyer PL, Schluter PL (2001) Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 165:884–886

    CAS  Google Scholar 

  10. Siegel S, Paszkiewicz E, Kirkpatrick C, Hinkel B, Oleson K (2001) Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 166:1742–1745

    CAS  Google Scholar 

  11. Thon WF, Baskin LS, Jonas U, Tanagho EA, Schmidt RA (1991) Neuromodulation of voiding dysfunction and pelvic pain. World J Urol 9:138–141

    Google Scholar 

  12. Siegel SW (1992) Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin North Am 19:163–170

    CAS  PubMed  Google Scholar 

  13. Janknegt RA, Weil EHJ, Eerdmans PHA (1997) Improving neuromodulation for refractory voiding dysfunctions: two-stage implant. Urology 49:358–362

    Article  CAS  PubMed  Google Scholar 

  14. Chai TC, Mamo GJ (2001) Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology 58:786–790

    CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Brian Doughty, our Medtronic Therapy Consultant, for his unrelenting energy, enthusiasm and expertise regarding InterStim therapy.

Author information

Authors and Affiliations

  1. Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Rd., Suite 438, Royal Oak, MI 48073, USA

    Kenneth M. Peters, Jeffrey M. Carey & David B. Konstandt

Authors
  1. Kenneth M. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey M. Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David B. Konstandt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth M. Peters.

Additional information

Editorial Comment: The authors nicely describe a very difficult subset of patients with interstitial cystitis. The patients in this paper have failed six prior treatment modalities before undergoing sacral neural modulation. In this small series the response to therapy and reoperation rate was dependent on the technique used to test and implant the device. Sacral neuromodulation using the staged technique does show significant benefit in the treatment of refractory interstitial cystitis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peters, K.M., Carey, J.M. & Konstandt, D.B. Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J 14, 223–228 (2003). https://doi.org/10.1007/s00192-003-1070-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-003-1070-3

Keywords

Search

Navigation